In conclusion, our meta-analysis indicates that HSP27 expression can be an effective biomarker for predicting the poor clinicopathological characteristics of NSCLC, including the differentiation degree, lymphatic metastasis, TNM stage, histological subtypes and tumor size. This evidence concerns the gene HSPB1 and non-small cell lung carcinoma.